Legal Representation
Attorney
Bradford S. Breen
USPTO Deadlines
Application History
41 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 7, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Mar 7, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Sep 14, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 22, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jul 21, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jul 21, 2021 | EX5G | S | SOU EXTENSION 5 GRANTED |
| Jul 15, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jul 15, 2021 | EXT5 | S | SOU EXTENSION 5 FILED |
| Jan 22, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jan 20, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jan 20, 2021 | EXT4 | S | SOU EXTENSION 4 FILED |
| Jan 20, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Jul 23, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jul 21, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jul 21, 2020 | EXT3 | S | SOU EXTENSION 3 FILED |
| Jul 21, 2020 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Jan 21, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jan 17, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jan 17, 2020 | EXT2 | S | SOU EXTENSION 2 FILED |
| Jan 17, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED |
| May 4, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 2, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 2, 2019 | EXT1 | S | SOU EXTENSION 1 FILED |
| May 2, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jan 29, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Dec 4, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 4, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Nov 14, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Oct 30, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 26, 2018 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Oct 26, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Oct 26, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Oct 18, 2018 | ALIE | A | ASSIGNED TO LIE |
| Oct 9, 2018 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Oct 9, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 17, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Sep 17, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Sep 17, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sep 13, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
| Jun 1, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| May 26, 2018 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in the treatment or diagnosis of cardiovascular, hormonal, oncology, inflammatory, diabetic, gastrointestinal, pain, muscle spasms, inflammatory, muscular, metabolic fungal, infectious, pulmonary diseases or disorders in humans
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Translation
The wording "MAIA" has no meaning in a foreign language.
Classification
International Classes
005